Analisis Return On Equity (ROE) Dalam Menilai Tingkat Kesehatan Perusahaan PT. Kalbe Farma Tbk
Jurnal Ekonomi Bisnis dan Manajemen · 30.12.2025 · 3 (2) · 141-148
DOI: 10.38204/ekobima.v3i2.2706 ↗Kurz gefasst
Fachartikel in der Zeitschrift Jurnal Ekonomi Bisnis dan Manajemen, online erschienen am 30.12.2025. Verfasst von Vina Ayu Lestari und 2 weiteren Autor:innen.
Abstract (Originalsprache)
This study analyzes the financial condition of PT Kalbe Farma Tbk from 2023 to 2025 using Return on Equity (ROE) as the primary assessment indicator. ROE is an essential profitability ratio that evaluates the company’s ability to generate net income based on shareholders’ equity. Quarterly ROE data were collected and averaged annually to detect patterns of change and assess the company’s financial status. The findings indicate that ROE in 2023 was very low, reflecting weak profitability and limitations in managing equity effectively. In 2024, ROE increased despite considerable fluctuations, indicating that the company was entering a recovery phase. In 2025, ROE rose steadily and exceeded the healthy threshold, demonstrating improved operational efficiency and stronger financial performance. Overall, the study concludes that PT Kalbe Farma Tbk experienced a gradual recovery and achieved a healthy financial condition by the end of the analysis period.
Zitieren
APA
Lestari, V. A., Usmar, A., & Kurniadi, Y. (2025). Analisis Return On Equity (ROE) Dalam Menilai Tingkat Kesehatan Perusahaan PT. Kalbe Farma Tbk. Jurnal Ekonomi Bisnis dan Manajemen, 3(2), 141-148. https://doi.org/10.38204/ekobima.v3i2.2706
Vancouver
Lestari VA, Usmar A, Kurniadi Y. Analisis Return On Equity (ROE) Dalam Menilai Tingkat Kesehatan Perusahaan PT. Kalbe Farma Tbk. Jurnal Ekonomi Bisnis dan Manajemen. 2025;3(2):141-148. doi:10.38204/ekobima.v3i2.2706
BibTeX
@article{Lestari2025,
author = {Lestari, Vina Ayu and Usmar, Andi and Kurniadi, Yudi},
title = {Analisis Return On Equity (ROE) Dalam Menilai Tingkat Kesehatan Perusahaan PT. Kalbe Farma Tbk},
journal = {Jurnal Ekonomi Bisnis dan Manajemen},
year = {2025},
volume = {3},
number = {2},
pages = {141--148},
doi = {10.38204/ekobima.v3i2.2706}
}
EUVIMED